about
Clinical use of alprostadil topical cream in patients with erectile dysfunction: a reviewLifestyle modifications and erectile dysfunction: what can be expected?Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experienceErectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort studySexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatmentRelationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.Sexual activity, erectile dysfunction, and incident cardiovascular events.Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.Men's Health Index: a pragmatic approach to stratifying and optimizing men's healthChanges in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey.Is erectile dysfunction a reliable indicator of general health status in men?The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review.The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.Risk factors for incident erectile dysfunction among community-dwelling men.Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Diabetes and sexual dysfunction: current perspectives.A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.Assessing the problem of counterfeit medications in the United Kingdom.Erectile dysfunction as a cardiovascular risk factor in patients with diabetes.The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.Prognostic value of exercise capacity among men undergoing pharmacologic treatment for erectile dysfunction: The FIT Project.Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.Hypertension might be a risk factor for erectile dysfunction: a meta-analysis.Sexual Function and Mortality in Older Men: The Concord Health and Ageing in Men Project.Evaluation of the Causes of Erectile Dysfunction in Patients Undergoing Penile Doppler Ultrasonography in Pakistan.Sexual dysfunction in men with COPD: impact on quality of life and survival.Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetesAssociation between Fragmented QRS and Left Ventricular Systolic Function in Patients with Erectile Dysfunction
P2860
Q26740510-2AA62649-2279-43AA-8064-0E2B508CA34CQ26866570-D8E892C5-7F88-4C46-863E-D09014CC6A2AQ28071503-24530D89-F512-46ED-BC97-2C07C8B421BAQ28709383-E5DE6E21-79E4-4E53-9E46-4DD5267CF2F2Q30398989-0F9CE8DF-C834-40D5-BF60-1998007E952BQ31151904-99A628A5-2041-434D-928E-498CFDA721C0Q33666324-4CF26911-5E3B-4B7A-AEA9-61F50F155B69Q33752512-96A3A944-0DD8-436A-97A1-EA46AF2A8C74Q34156375-2D95A6FC-C19A-4FB8-8E7E-9106808F6015Q34506843-2FE3528A-4A22-4F69-9BF4-614EE4DBEAEFQ35007546-A262E8FA-9F9A-4EBA-907D-7C591DA0BE57Q35643349-47386DA1-587A-46E7-9B64-1FBCA772E2E5Q35914768-353DFDDA-5635-471F-B623-20E7E9761ED0Q36399555-606A627F-2459-4BF0-909E-13BED5ED2BC3Q36513914-45D01260-D838-45C3-BD17-B4F468724B47Q36542984-CB761140-2A30-4308-AB39-8BF757C3A75FQ36861695-404092F6-AD01-49B7-94C9-FC5CB1E58ADCQ37630425-003B7263-FB10-4FC5-BD2F-0DC5F4F62A8CQ37820206-D6375A51-F54D-4D0B-B937-AD55B0A6A1E6Q37954383-0DDD564C-B7C7-428B-B02E-7939C88AA91CQ38040688-1B0D2FFC-0BAB-43CC-914B-AAACA919462DQ38109957-66B34FE9-59EE-4E37-97FA-AC0D7F91CD2EQ38642909-293B21B8-33B6-431A-9C52-FD0FF7388147Q39195242-89FA72DA-6518-453E-9B9F-19F0A565B336Q40298861-A1EBE5C8-A9B7-4F87-BEFB-AC318D1A4486Q40635953-C6EBB1E1-07B6-4579-A890-FC0352A152DDQ40723709-A3CA36CC-2E57-4F53-B79E-C941A5B33377Q41823680-12E12481-B7FF-470C-BE20-1B251B74B7FFQ48421412-2964BFC4-675A-4652-8E0E-4AAB3217B1D6Q58842179-67F30927-16BE-4D1B-B31B-80BD4D1B648FQ59131706-7558B477-4026-401C-BAF2-D235CDB945A3
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Erectile dysfunction and mortality
@ast
Erectile dysfunction and mortality
@en
type
label
Erectile dysfunction and mortality
@ast
Erectile dysfunction and mortality
@en
prefLabel
Erectile dysfunction and mortality
@ast
Erectile dysfunction and mortality
@en
P2093
P2860
P1476
Erectile dysfunction and mortality
@en
P2093
Andre B Araujo
Gretchen R Chiu
John B McKinlay
Peter Ganz
Raymond C Rosen
Susan A Hall
Thomas G Travison
Varant Kupelian
P2860
P304
P356
10.1111/J.1743-6109.2009.01354.X
P577
2009-06-15T00:00:00Z